The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

which treat diabetes and obesity, respectively. While these two medicines are grabbing most of the attention, it's worth ...

The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The Hawkins County Board of Education will consider entering a national lawsuit regarding alleged insulin price fixing that drove up the cost of healthcare nationwide, including health insurance costs ...

The continued use of a new obesity treatment can lead to weight loss of up to 23 per cent and a 94 per cent reduction in ...

It is one of the leading products in this niche ... in developing novel medicines. Eli Lilly has been a leader in the ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

As pharma giants Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are raking in the cash from their weight loss and ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.